APA (7th ed.) Citation

Matsumura, M., Nakatani, Y., Tanka, S., Aoki, C., Sagara, M., Yanagi, K., . . . Aso, Y. (2017). Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM). Diabetes therapy, 8(4), 821-827. https://doi.org/10.1007/s13300-017-0274-3

Chicago Style (17th ed.) Citation

Matsumura, Mihoko, Yuki Nakatani, Seiichi Tanka, Chie Aoki, Masaaki Sagara, Kazunori Yanagi, Kunihiro Suzuki, and Yoshimasa Aso. "Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)." Diabetes Therapy 8, no. 4 (2017): 821-827. https://doi.org/10.1007/s13300-017-0274-3.

MLA (9th ed.) Citation

Matsumura, Mihoko, et al. "Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)." Diabetes Therapy, vol. 8, no. 4, 2017, pp. 821-827, https://doi.org/10.1007/s13300-017-0274-3.